HbA1c in Early Diabetic Pregnancy and Pregnancy Outcomes
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 20 of the 20 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—To assess the association between first-trimester HbA1c (A1C) and the risk of adverse pregnancy outcomes in type 1 diabetic pregnancies. RESEARCH DESIGN AND METHODS—We identified all pregnant diabetic women in a Danish county from 1985 to 2003. A1C values from first trimester were collected, and pregnancy outcome was dichotomized as good (i.e., babies surviving the 1st month of life without major congenital abnormalities) and adverse (i.e., spontaneous and therapeutic abortion, stillbirth, neonatal death, or major congenital abnormalities detected within the 1st month). The prevalence of adverse outcomes was calculated according to quintiles of A1C. We computed receiver operating characteristic and lowess curve estimates and fitted logistic regression models to calculate prevalence odds ratio while adjusting for confounding by White class and smoking status. RESULTS—Of 573 pregnancies, 165 (29%) terminated with adverse outcomes. The prevalence of adverse outcomes varied sixfold from 12% (95% CI 7.2–17) in the lowest to 79% (60–91) in the highest quintile of A1C exposure. From A1C levels >7%, we found an almost linear association between A1C and risk of adverse outcome, whereby a 1% increase in A1C corresponded to 5.5% (3.8–7.3) increased risk of adverse outcome. CONCLUSIONS—Starting from a first-trimester A1C level slightly <7%, there is a dose-dependent association between A1C and the risk of adverse pregnancy outcome without indication of a plateau, below which the association no longer exits. A1C, however, seems to be of limited value in predicting outcome in the individual pregnancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational studies in preexisting diabetes and pregnancy show the lowest rates of adverse fetal outcomes in association with A1C <6-6.5% (<42-48 mmol/mol) early in gestation (4-6,40).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [6]
In the citing paper
“Maternal hyperglycemia in the first few weeks of pregnancy increases the risk of fetal malformations, spontaneous abortions, and perinatal mortality (14–18).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [15]
In the citing paper
“Maternal hyperglycemia in the first few weeks of pregnancy increases the risk of fetal malformations, spontaneous abortions, and perinatal mortality (14–18).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [15]
In the citing paper
“Maternal hyperglycemia in the first few weeks of pregnancy increases the risk of fetal malformations, spontaneous abortions, and perinatal mortality (14–18).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [15]
Citations
Cites
Robust Locally Weighted Regression and Smoothing Scatterplots
Cleveland, W. S. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10481038 · Cited by 11,594 · cited 1×
“We used lowess curve estimates to assess the association between A1C and the risk of adverse or early adverse pregnancy outcome (16).”
MethodDose-Response and Trend Analysis in Epidemiology: Alternatives to Categorical Analysis
Greenland, S. (1995) · Epidemiology · doi:10.1097/00001648-199507000-00005 · Cited by 1,085 · cited 1×
“Early adverse outcome 148 (26) (22–30) 85 (18) (15–22) 63 (64) (54–72) 3.”
Mills, J. L., Baker, L., & Goldman, A. S. (1979) · Diabetes · doi:10.2337/diab.28.4.292 · Cited by 435
The Pregnant Diabetic and Her Newborn
Farquhar, J. W. (1977) · Archives of Disease in Childhood · doi:10.1136/adc.52.8.671 · Cited by 406
Mills, J. L., Simpson, J. L., Driscoll, S. G., Jovanovic-Peterson, L., Van Allen, M., Aarons, J. H., Metzger, B., Bieber, F. R., Knopp, R. H., Holmes, L. B., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812223192501 · Cited by 402
Preconception Care of Diabetes: Glycemic Control Prevents Congenital Anomalies
Kitzmiller, J. L. (1991) · JAMA · doi:10.1001/jama.1991.03460060063025 · Cited by 397
Suhonen, L., Hiilesmaa, V., & Teramo, K. (2000) · Diabetologia · doi:10.1007/s001250050010 · Cited by 302 · cited 1×
“(8) found that even a slightly raised A1C level was positively associated with an increased risk of major congenital abnormalities.”
BackgroundJeppsson, J. O., Jerntorp, P., Sundkvist, G., Englund, H., & Nylund, V (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.10.1867 · Cited by 299 · cited 1×
“Since 1985, A1C has been analyzed according to the standards used in the Diabetes Control and Complications Trial with an essentially unchanged analytical methodology (14).”
MethodGreene, M. F., Hare, J. W., Cloherty, J. P., Benacerraf, B. R., & Soeldner, J. S. (1989) · Teratology · doi:10.1002/tera.1420390303 · Cited by 270
Hanson, U., Persson, B., & Thunell, S. (1990) · Diabetologia · doi:10.1007/bf00401047 · Cited by 176
Cited by
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
Managing preexisting diabetes for pregnancy
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-9020 · Cited by 476
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s014 · Cited by 381
Preconception care for women with diabetes and prevention of major congenital malformations
Kitzmiller, J. L., Wallerstein, R., Correa, A., & Kwan, S. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20734 · Cited by 369
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
13. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s013 · Cited by 332
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s014 · Cited by 268
14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s014 · Cited by 265
Tennant, P. W. G., Glinianaia, S. V., Bilous, R. W., Rankin, J., & Bell, R. (2014) · Diabetologia · doi:10.1007/s00125-013-3108-5 · Cited by 249
“Using LOWESS, Nielsen et al demonstrated an approximately linear association between increasing first-trimester HbA1c above 53 mmol/mol (7%) and the risk of ‘adverse outcome’, although this included congenital anomalies and elective terminations [30].”
Method15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
Hughes, R. C. E., Moore, M. P., Gullam, J. E., Mohamed, K., & Rowan, J. (2014) · Diabetes Care · doi:10.2337/dc14-1312 · Cited by 238
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
Jensen, D. M., Korsholm, L., Ovesen, P., Beck-Nielsen, H., Moelsted-Pedersen, L., Westergaard, J. G., Moeller, M., & Damm, P. (2009) · Diabetes Care · doi:10.2337/dc08-2061 · Cited by 227
“(5) reported a dose-dependent association between the risk for adverse pregnancy outcome (abortion, stillbirth, neonatal death, or major congenital malformation) and first trimester A1C without any threshold value.”
BackgroundSelf-citationGuerin, A., Nisenbaum, R., & Ray, J. G. (2007) · Diabetes Care · doi:10.2337/dc07-0278 · Cited by 215
13. Management of Diabetes in Pregnancy
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s016 · Cited by 179
Wahabi, H. A., Fayed, A., Esmaeil, S., Elmorshedy, H., Titi, M. A., Amer, Y. S., Alzeidan, R. A., Alodhayani, A. A., Saeed, E., Bahkali, K. H., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0237571 · Cited by 130
Wahabi, H. A., Alzeidan, R. A., & Esmaeil, S. A. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-792 · Cited by 126
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 172
12. Management of Diabetes in Pregnancy
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s015 · Cited by 135
Use of hemoglobin A1c as an early predictor of gestational diabetes mellitus
Fong, A., Serra, A. E., Gabby, L., Wing, D. A., & Berkowitz, K. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.06.016 · Cited by 94
Role of first trimester HbA1c as a predictor of adverse obstetric outcomes in a multi-ethnic cohort.
Mañé, L., Flores-Le Roux, J. A., Benaiges, D., Rodríguez, M., Marcelo, I., Chillarón, J. J., Pedro-Botet, J., Llauradó, G., Gortazar, L., Carreras, R., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2581 · Cited by 91
“Although in women with pre-existing diabetes, early pregnancy HbA1c directly correlates with pregnancy outcomes (22-26), this association is less clear in those without diabetes.”
BackgroundRys, P., Ludwig‐Słomczyńska, A. H., Cyganek, K., & Malecki, M. T. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0804 · Cited by 90
Ludvigsson, J. F., Neovius, M., Söderling, J., Gudbjörnsdottir, S., Svensson, A.-M., Franzén, S., Stephansson, O., & Pasternak, B. (2018) · BMJ · doi:10.1136/bmj.k2638 · Cited by 86
Eidem, I., Stene, L. C., Henriksen, T., Hanssen, K. F., Vangen, S., Vollset, S. E., & Joner, G. (2010) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016349.2010.518594 · Cited by 77
Vascular Complications in the Diabetic Pregnancy
Leguizamón, G. F., Trigubo, D., Pereira, J. I., Vera, M. F., & Fernández, J. A. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0586-5 · Cited by 79
Ludvigsson, J. F., Neovius, M., Söderling, J., Gudbjörnsdottir, S., Svensson, A.-M., Franzén, S., Stephansson, O., & Pasternak, B. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1974 · Cited by 75
Klemetti, M. M., Nuutila, M. E., Tikkanen, M., Kari, M. A., Hiilesmaa, V., & Teramo, K. (2012) · Diabetologia · doi:10.1007/s00125-012-2627-9 · Cited by 82
First‐trimester glycosylated hemoglobin in women at high risk for gestational diabetes
Amylidi, S., Mosimann, B., Stettler, C., Fiedler, G. M., Surbek, D., & Raio, L. (2016) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12784 · Cited by 67
Diabetic-associated stillbirth: incidence, pathophysiology, and prevention
Dudley, D. J. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.03.001 · Cited by 67
Berg, M., & Sparud‐Lundin, C. (2009) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-9-27 · Cited by 67
Hypoglycemia in Type 1 Diabetic Pregnancy
Heller, S., Damm, P., Mersebach, H., Skjøth, T. V., Kaaja, R., Hod, M., Durán-García, S., McCance, D., & Mathiesen, E. R. (2010) · Diabetes Care · doi:10.2337/dc09-1605 · Cited by 63
“0% advocated to optimize pregnancy outcome (10,11), minimizing the risk of severe hypoglycemia is a major challenge to those caring for pregnant women with type 1 diabetes.”
BackgroundContemporary type 1 diabetes pregnancy outcomes: impact of obesity and glycaemic control
Abell, S. K., Boyle, J. A., Courten, B., Knight, M., Ranasinha, S., Regan, J., Soldatos, G., Wallace, E. M., Zoungas, S., & Teede, H. J. (2016) · Medical Journal of Australia · doi:10.5694/mja16.00443 · Cited by 60
Wyckoff, J., Lapolla, A., Asias-Dinh, B. D., Barbour, L. A., Brown, F. M., Catalano, P. M., Corcoy, R., Renzo, G. C. D., Drobycki, N., Kautzky‐Willer, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf288 · Cited by 60
The maternal experience of having diabetes in pregnancy
Nolan, J. A., McCrone, S., & Chertok, I. R. A. (2011) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2011.00646.x · Cited by 54
Diabetic-Associated Stillbirth: Incidence, Pathophysiology, and Prevention
Dudley, D. J. (2007) · Clinics in Perinatology · doi:10.1016/j.clp.2007.09.003 · Cited by 60
Bonifacio, E. E., Pflüger, M., Marienfeld, S., Winkler, C., Hummel, M., & Ziegler, A. (2008) · Diabetologia · doi:10.1007/s00125-008-1022-z · Cited by 54
Lemaître, M., Ternynck, C., Bourry, J., Baudoux, F., Subtil, D., & Vambergue, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab769 · Cited by 47
“All pregnancies were analyzed but only pregnancies of women with T1D were included.”
BackgroundInfluentialVricella, L. K., Gawron, L. M., & Louis, J. M. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.02.011 · Cited by 43
Contraception, and pregnancy in adolescents with type 1 diabetes: a review
Ethel Codner, D., Néstor Soto, I., & Merino, P. M. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00825.x · Cited by 41
Time in range in pregnancy: is there a role?
Wyckoff, J. A., & Brown, F. M. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0103 · Cited by 39
Glucose Control during Labor and Delivery
Ryan, E. A., & Al‐Agha, R. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0450-4 · Cited by 43
Management of pregestational diabetes mellitus: a comparison of guidelines
Tsakiridis, I. G., Mamopoulos, A. M., Athanasiadis, A. P., Kourtis, A., & Dagklis, T. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1719481 · Cited by 36
Ison, H. E., Griffin, E. L., Parrott, A., Shikany, A. R., Meyers, L., Thomas, M., Syverson, E. P., Demo, E. M., Fitzgerald, K. K., Fitzgerald‐Butt, S. M., et al. (2021) · Journal of Genetic Counseling · doi:10.1002/jgc4.1498 · Cited by 41
“…dose- dependent relationship between hemoglobin A1c and risk for fetal malformations, a high A1c level early in pregnancy would increase the concern for maternal diabetes as a contributor to the development of fetal CHDs (Helle & Priest, 2020; Nielsen et al., 2006; Wender- Ozegowska et al., 2005).”
BackgroundFinneran, M. M., Kiefer, M. K., Ware, C. A., Buschur, E., Thung, S., Landon, M. B., & Gabbe, S. G. (2019) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2019.100069 · Cited by 38
Risk Factor Profile and Pregnancy Outcome in Women with Type 1 and Type 2 Diabetes Mellitus
Handisurya, A., Bancher‐Todesca, D., Schober, E., Klein, K., Tobler, K., Schneider, B. K., Pollak, A. J., Husslein, P. W., Luger, A., & Kautzky‐Willer, A. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2033 · Cited by 37
Type 1 Diabetes: Management in Women From Preconception to Postpartum
Buschur, E., & Polsky, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa931 · Cited by 36
Insulin treatment in diabetic pregnancy
Mathiesen, E. R., & Vaz, J. A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.876 · Cited by 32
“Moreover, there was no indication of a plateau below which the association did not apply [17].”
BackgroundLiang, J.-T., Gui, Y., Wang, W., Gao, S., Li, J., & Song, H. (2010) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20654 · Cited by 30
Tennant, P. W. G., Bilous, R., Prathapan, S., & Bell, R. (2015) · Diabetes Care · doi:10.2337/dc14-1888 · Cited by 28
“We observed a familiar J-shaped association between periconception A1C and adverseoutcome (39),with the risk increasing by 2–3% per mmol/mol $47 mmol/mol.”
BackgroundPre-Gestational Diabetes and Pregnancy Outcomes
Ali, D. S., Davern, R., Rutter, E., Coveney, C., Devine, H., Walsh, J., Higgins, M., & Hatunic, M. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00932-9 · Cited by 28
Nakanishi, K., Kanagawa, T., Fujikawa, K., Ishii, K., & Waguri, M. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15015 · Cited by 29
“5% to reduce the risk of congenital malformations based on four studies.(3,7,13,15,26) However, it remains unclear whether these HbA1c cutoff values during the organogenesis period could be applied to Japanese pregnant women because most of the participants were Europeans and Americans.”
BackgroundWyckoff, J., Lapolla, A., Asias-Dinh, B. D., Barbour, L. A., Brown, F. M., Catalano, P. M., Corcoy, R., Renzo, G. C. D., Drobycki, N., Kautzky‐Willer, A., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf116 · Cited by 30
Samuelsson, U., Lindell, N., Bladh, M. K., Åkesson, K., Carlsson, A., & Josefsson, A. (2015) · Diabetologia · doi:10.1007/s00125-015-3716-3 · Cited by 26
Kiefer, M. K., Finneran, M. M., Ware, C. A., Fareed, N., Joseph, J. J., Thung, S., Costantine, M. M., Landon, M. B., Gabbe, S. G., & Venkatesh, K. K. (2022) · Diabetic Medicine · doi:10.1111/dme.14822 · Cited by 29
Endocrine emergencies in pregnancy
Khoo, C. M., & Lee, K. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.08.005 · Cited by 27
Soriano, L. C., García‐Rodríguez, L. A., Brodovicz, K. G., Massó-González, E. L., Bartels, D. B., & Hernández–Díaz, S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13275 · Cited by 24
“The corresponding ORs for cardiac malformations were 4.18 (95% CI, 2.53- 6.89) with T1D and 1.47 (95% CI, 0.59-3.64) with T2D.”
BackgroundResultInfluentialApplication of glycated hemoglobin in the perinatal period.
Yu, H., Qi, X., & Wang, X. (2014) · PubMed · Cited by 30
Diabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 22
Pregnancy complicated by diabetes: what is the best level of HbA1c for conception?
Lapolla, A., Dalfrà, M. G., & Fedele, D. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0199-z · Cited by 20
“Nielsen et al. [ 18 ] HbA1C [ 7% ?1% HbA1c increase OR 5.5(3.8–7.3) CM”
BackgroundInfluentialChirwa, S., Nwabuisi, C. R., Ladson, G. M., Korley, L., Whitty, J. E., Atkinson, R., & Clark, J. T. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15102287 · Cited by 19
“Monitoring and evaluating good sleep quality as well as HbA1c can help guide non-drug interventions for curtailing adverse pregnancy outcomes like GD [55].”
BackgroundSchmidt, A. B., Lund, M., Corn, G., Halldorsson, T. I., Øyen, N., Wohlfahrt, J., Olsen, S. F., & Melbye, M. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz342 · Cited by 17
Planejamento, metas e monitorização do diabetes durante a gestação
Zajdenverg, L., Façanha, C. F. S., Dualib, P. M., Golbert, A., Negrato, C. A., & Bertoluci, M. C. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-12 · Cited by 26
Development and validation of a cost–utility model for Type 1 diabetes mellitus
Wolowacz, S. E., Pearson, I. V., Shannon, P. A., Chubb, B., Gundgaard, J., Davies, M. J., & Briggs, A. H. (2015) · Diabetic Medicine · doi:10.1111/dme.12663 · Cited by 16
Clinical analysis of 2860 cases of diabetes in pregnancy: a single-center retrospective study
Chen, J., Wang, Z., Wu, W., Chen, H., Zhong, C., Liang, L., & Li, Y. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04712-0 · Cited by 16
Diagnosis and management of gestational diabetes mellitus guidelines by DIPSI (Revised)
Seshiah, V., Balaji, V., Chawla, R., Gupta, S., Jaggi, S., Anjalakshi, C., Divakar, H., Banerjee, S., Bhavatharini, N., & Thanawala, U. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01222-3 · Cited by 17
Importance of early elevated maternal HbA1c levels in identifying adverse fetal and neonatal events
Yu, H., Wang, J., Shrestha, Y., Hu, Y., Ma, Y., Ren, L., Zhang, J., & Li, J. (2019) · Placenta · doi:10.1016/j.placenta.2019.07.008 · Cited by 16
Preexisting Diabetes and Pregnancy
Kitzmiller, J. L., Ferrara, A. M., Peng, T., Cissell, M. A., & Kim, C. (2018) · Europe PMC (PubMed Central) · Cited by 28
Song, Y., Zhai, X., Bai, Y., Liu, C., & Zhang, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1218602 · Cited by 17
Hauffe, F., Fauzan, R., Schohe, A., Scholle, D., Sedlacek, L., Scherer, K., Klapp, C., Ramsauer, B., Henrich, W., Schlembach, D., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14350 · Cited by 11
Stenhouse, E., & Letherby, G. (2009) · Midwifery · doi:10.1016/j.midw.2009.06.004 · Cited by 11
“Addressing this issue, much of the research is focused on increasing the uptake of preconception care (Hawthorne, 2005), reducing biochemical markers such as HbA1c (Nielsen et al., 2006), and close surveillance of the fetus (Inkster et al.”
BackgroundClinical analysis of diabetes in pregnancy with stillbirth
Wang, Z., Chen, J., Long, T., Liang, L., Zhong, C., & Li, Y. (2023) · Medicine · doi:10.1097/md.0000000000033898 · Cited by 12
“3%.[35] Another result of poor glycemic control is the risk of diabetic ketoacidosis.”
BackgroundEarly diabetes screening in pregnancy
Shinar, S., & Berger, H. M. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12484 · Cited by 11
Polycystic ovary syndrome and offspring risk of congenital heart defects: a nationwide cohort study
Schmidt, A. B., Lund, M., Wohlfahrt, J., & Melbye, M. (2020) · Human Reproduction · doi:10.1093/humrep/deaa168 · Cited by 10
Chen, X., Zhang, Y., Chen, H., Dou, Y., Wang, Y., He, W., Ma, X., Sheng, W., Yan, W., & Huang, G. (2023) · JMIR Public Health and Surveillance · doi:10.2196/46986 · Cited by 9
“Several studies have investigated the adverse effect of elevated HbA 1c levels on SPL risk only among pregnant women with diabetes and have reported conflicting findings [12-14 , 22].”
BackgroundResultDisney, E. A., Sanders, J. N., Turok, D. K., & Gawron, L. M. (2020) · Women s Health Reports · doi:10.1089/whr.2020.0042 · Cited by 9
Nielsen, G. L., Welinder, L. G., & Johansen, M. B. (2017) · Diabetic Medicine · doi:10.1111/dme.13312 · Cited by 9
Self-citationGhodrati, F., Saadatmand, N., Gholamzadeh, S., & Akbarzadeh, M. (2019) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr.2019.82975 · Cited by 9
Preconception counseling in women with diabetes: the SEARCH for diabetes in youth study
Roberts, A. J., Sauder, K., Stafford, J. M., Malik, F. S., Pihoker, C., Boghossian, N. S., Ehrlich, S., Pettitt, D. J., Dabelea, D., Bellatorre, A., et al. (2023) · Clinical Diabetes · doi:10.2337/cd22-0030 · Cited by 7
Insulin Detemir in Pregnancy: A Small but Significant Step Forward?
McElduff, A. (2012) · Diabetes Care · doi:10.2337/dc12-0971 · Cited by 8
Feasibility of Neonatal Pulse Wave Velocity and Association with Maternal Hemoglobin A1c
Chen, S., Chetty, S., Lowenthal, A., Evans, J. M., Vu, C. N., Stauffer, K. J., Lyell, D. J., & Tierney, E. S. S. (2014) · Neonatology · doi:10.1159/000366467 · Cited by 8
Handisurya, A., Bancher‐Todesca, D., Kamyar, M. R., Lemmens‐Gruber, R., & Kautzky‐Willer, A. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0870-1 · Cited by 7
McCance, D. R., & Cassidy, L. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch71 · Cited by 9
Chen, H., Tan, Q., Lai, S., Mai, H., & Wang, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-78679-7 · Cited by 8
IGF-1 is associated with fetal growth and preterm delivery in type 1 diabetic pregnancy
Lauszus, F. F., & Fuglsang, J. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1134477 · Cited by 7
Pregestational diabetes increases fetoplacental vascular resistance in rats
Vajnerová, O., Kafka, P., Kratzerová, T., Chalupský, K., & Hampl, V. (2018) · Placenta · doi:10.1016/j.placenta.2018.01.008 · Cited by 8
McCance, D. R., & Holmes, V. A. (2010) · Wiley eBooks · doi:10.1002/9781444315196.ch10 · Cited by 7
Preconception SGLT2 or DPP4 inhibitor use and adverse pregnancy outcomes
Ray, J. G., Harel, Z., Gilbert, R. E., Wald, R., Berger, H. M., & Park, A. L. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110946 · Cited by 6
Improving Outcomes in Pregnant Women With Type 1 Diabetes
Hod, M., & Jovanovič, L. (2007) · Diabetes Care · doi:10.2337/dc07-0488 · Cited by 6
A Comprehensive Approach to Care of Women of Advanced Maternal Age
Dillon, C., Ennen, C. S., Bailey, K. J., & Thagard, A. S. (2019) · Nursing for Women s Health · doi:10.1016/j.nwh.2019.02.002 · Cited by 6
Aung, N. L. (2024) · Clinical Diabetes · doi:10.2337/cd24-0009 · Cited by 6
Soriano, L. C., Rodríguez, L. A. G., Brodovicz, K. G., Massó-González, E. L., Bartels, D. B., & Hernández–Díaz, S. (2018) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4553 · Cited by 5
“For instance, the risk of birth defects rises as glycosylated hemoglobin (HbA1C) levels increase above 6%.(11-14) The National Institute for Health and Clinical Excellence guidelines on the management of diabetes encourage women of childbearing age with diabetes to avoid unplanned pregnancies and to monitor blood gluc…”
BackgroundRyan, L. W. K., Weiying, L., Wright, A., & Tan, L. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009507189 · Cited by 4
The Power of Small Conversations: Bridging the Gap Between Diabetes and Pregnancy Planning
Jazdarehee, A., Shearer, D., Thompson, D. M., Lee, J., Dahl, M., Khurana, R., & Pawłowska, M. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.01.007 · Cited by 4
Value of HbA1c in Obese Women with Gestational Diabetes
Oben, A. G., Jauk, V. C., Battarbee, A. N., Longo, S. A., Szychowski, J. M., Tita, A., & Harper, L. M. (2021) · American Journal of Perinatology · doi:10.1055/s-0041-1740060 · Cited by 5
Ogassavara, J., Dualib, P. M., Mattar, R., Dib, S. A., & de Almeida-Pititto, B. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2022-0483 · Cited by 7
“Intensive glycemic control before conception and during pregnancy is essential to reduce the occurrence of these adverse outcomes (16-21).”
BackgroundHbA1C Level in 2nd and 3rd Trimester with Pregnancy Outcome in Diabetic Patients
Sengupta, R., Jesmen, S., Banu, L. A., & Habib, S. H. (2012) · BIRDEM Medical Journal · doi:10.3329/birdem.v2i1.12358 · Cited by 4
Jang, M., Kim, M., & Suh, H. S. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104572 · Cited by 4
Salih, J. M. (2024) · Intern J Endocrinol Metab · doi:10.5812/ijem-153529 · Cited by 3
Falqui, S. G., Bardanzellu, F., Mecarini, F., Fanos, V., & Neroni, P. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1798397 · Cited by 3
Metadata
- Authors
- Nielsen, G. L., Møller, M., & Sørensen, H. T.
- Affiliations
- Aalborg University Hospital (DK)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-12-01
- Volume
- 29
- Issue
- 12
- Pages
- 2612-2616
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2158990308
- Cited by
- 140
- References
- 19
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 7 · 2020: 11 · 2019: 9 · 2018: 13 · 2017: 2 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 8 · 2012: 6
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HbA1c, type 1 diabetes, diabetes in pregnancy, adverse pregnancy outcomes, stillbirth, neonatal death, congenital malformations, miscarriage, therapeutic abortion, dose-response relationship
- MeSH terms
- Congenital Abnormalities, Denmark, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Infant, Newborn, Pregnancy, Pregnancy in Diabetics, Pregnancy Outcome, Pregnancy Trimester, First, Smoking, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.